Montreal Ovarian Cancer Initiative

Montreal Ovarian Cancer Initiative

September 12, 2005 11:46 ET

Fundraiser in Support of MOI: The Montreal Ovarian Cancer Initiative

MONTREAL, QUEBEC--(CCNMatthews - Sept. 12, 2005) - A fundraiser in support of the Montreal Ovarian Cancer Initiative (MOI) will take place on Thursday, September 15, 2005 at Schwartz's Montreal Hebrew Delicatessen 3895 Blvd. St. Laurent, Montreal, between the hours of 6am to 9pm. All proceeds of the day's sales will be donated to MOI.

MOI represents a unique collaboration between two leading research groups, one from the Universite de Montreal led by Dr. Diane Provencher of the Centre Hospitalier de l'Universite de Montreal (CHUM), the other from McGill University, led by Dr. Walter Gotlieb of the Sir Mortimer B. Davis - Jewish General Hospital. In addition to raising funds in support of research that will focus on new strategies in the clinical management of ovarian cancer, MOI seeks to heighten awareness of and educate women about this most deadly disease that claims approximately 1,500 Canadian women each year. One in 58 women will be affected by ovarian cancer in their lifetime.

Since ovarian cancer is usually detected only in its later stages, it has come to be known as the "cancer that whispers". It is a particularly deadly disease. Over 70% of patients with ovarian cancer are diagnosed at an advanced stage of disease and despite modifications in treatment regimens, survival rates have changed little over the past 30 years. Ovarian cancer still has a mortality rate of 60%. Unlike other cancers, awareness of and screening for ovarian cancer remains much too low.

About the Centre hospitalier de l'Universite de Montreal (CHUM)

The Centre hospitalier de l'Universite de Montreal (CHUM) provides specialized and subspecialized services to a regional and supraregional clientele. Within its more immediate coverage area, it also offers general and specialized hospital care and services. All of these services contribute to teaching, research, the assessment of technologies and healthcare methodologies, which are provided within integrated networks. The CHUM also contributes to promoting health in continuity with front-line services.

Hotel-Dieu, Hopital Notre-Dame and Hopital Saint-Luc form the CHUM, which counts 10,000 employees, 900 physicians, 330 researchers, 5000 students and trainees, and 800 volunteers, who provide services to more than 500,000 patients each year.

About the Institut du cancer de Montreal (ICM)

The Institut du cancer de Montreal was founded in 1947, and subsequently became affiliated with the Hopital Notre-Dame, with the clear mandate of encouraging and supporting fundamental and clinical research in oncology. The ICM has since extended its affiliation to the Universite de Montreal, and in doing so, added training and teaching to its mandate. Today the ICM is affiliated with the CHUM and the Universite de Montreal, and remains an independent non-profit organization that solicits public and private donations. The ICM supports cancer research and training by awarding scholarships and grants for innovative research. For more information, please visit

About the Jewish General Hospital (JGH)

Since 1934, the Sir Mortimer B. Davis - Jewish General Hospital, a 637-bed McGill University teaching hospital, has provided "Care for All," serving patients of diverse religious, linguistic and cultural backgrounds from Montreal, throughout Quebec and beyond. As one of the province's leading acute-care hospitals, the JGH has earned a reputation for excellence, continually expanding and upgrading its treatment and teaching programs as well as leading research programs underway at the hospital's Lady Davis Institute for Medical Research, Quebec's second largest biomedical research centre. For more, please visit

Contact Information